Skip to main content

Site notifications

CON-TGO91-354 - Juno Pharmaceuticals Pty Ltd

Product names
  • AUST R 209215 - TIROSTAT tirofiban (as hydrochloride) 12.5mg/50mL Concentrated Injection for infusion Vial
  • AUST R 209216 - TIROFIBAN JUNO tirofiban (as hydrochloride) 12.5mg/50mL Concentrated Injection for infusion Vial
Decision Date
Duration
The consent is effective for all batches manufactured between 1 September 2020 and 1 March 2021.
Non-compliance with standard

The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.

Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines

Help us improve the Therapeutic Goods Administration site